| Literature DB >> 24902490 |
Brian G Bell1, Rachel Spencer, Anthony J Avery, Stephen M Campbell.
Abstract
BACKGROUND: The majority of patient contacts occur in general practice but general practice patient safety has been poorly described and under-researched to date compared to hospital settings. Our objective was to produce a set of patient safety tools and indicators that can be used in general practices in any healthcare setting and develop a 'toolkit' of feasible patient safety measures for general practices in England.Entities:
Mesh:
Year: 2014 PMID: 24902490 PMCID: PMC4060097 DOI: 10.1186/1471-2296-15-110
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Key sources of statements for the RAND consensus panel
| PMCPA Primary Medical Care Provider Accreditation [ | The RCGP (Royal College of General Practitioners) commissioned the University of Manchester to begin work on this quality assessment scheme in 2007. PMCPA version 1 has been piloted in 36 UK practices, half of the practices achieved ≥90% on core criteria, 9 practices achieved 100%. The data from the pilot shows that practices were able to meet the criteria. | The researchers liaised with the CQC (Care Quality Commission) to ensure that the development of PMPCA was relevant to future national aims for general practice. |
| EPA European Practice Assessment [ | A framework for general practice management made up of quality indicators shared by six European countries. Indicators were derived from a two-round postal Delphi questionnaire in general practice settings in Belgium, France, Germany, The Netherlands, Switzerland and the United Kingdom using the Rand Appropriateness Method. | A number of the indicators might be considered in a safety context, this work was also used to inform the PMCPA. TOPAS Europe are a Dutch organisation who are implementing and extending EPA, see; |
| Multiple prescribing literature sources [ | RAND consensus output and documents from UK organisations such as NPSA (National Patient Safety Agency) and BNF (British National Formulary). Reports of trials of interventions to improve medications management. | Results of a RAND process focusing exclusively on indicators that are drug specific will be published separately, indicators in relation to safety of prescribing systems (especially electronic systems) and medicines management were considered here. |
| Multiple resources on interface of general practice and secondary care e.g [ | Focus on the literature relevant to general practice, mostly small intervention pilot studies and guidelines. | Indicators were only considered if they were under the direct control of the family practitioner, for example, offering a review post discharge. |
Inclusion and exclusion criteria
| Inclusion criteria | |
| 1. | The tools, sets of indicators or individual indicators represent good practice in the field of patient safety in primary care |
| 2. | Preferred tools, sets of indicators or individual indicators that could be extracted electronically |
| Exclusion criteria | |
| 1. | We excluded tools, sets of indicators or individual indicators that describe a pattern of care that is so unusual in UK general practice that the yield is likely to be too low to justify inclusion in the RAND process i.e. items relating to general anaesthesia |
| 2. | Tools, sets of indicators or individual indicators seen as statutory in the UK were excluded (i.e. items relating to the introduction of an electronic health record (EHR) |
A new taxonomy of patient safety in general practice
| Accessibility | Availability | Availability | User Evaluation |
| Safety | Background Systems | Safety of clinical care | Adverse Events/Errors |
| | Management | Safety of Interpersonal care | User Evaluation |
| | Premises | | |
| | Learning Organisation | | Harm Improvement |
| | Workforce/Team (Includes; skills, training, qualifications, communication, and responsibilities) | | |
| | Interface | | |
| Patient Care/Involvement |
Summary of necessity (and UK feasibility) ratings for round 2
| | | |
| Indicators (n) | 142 | 138 |
| Necessary (%) | 56 | ---- |
| Feasible (%) | ----- | 54 |
| Median 1-3 (n) | 3 | 0 |
| Median 4-6 (n) | 48 | 49 |
| Median 7-9 (n) | 91 | 89 |
| Agreement (%) | 81 | 77 |
| Equivocal (%) | 18 | 22 |
| Disagreement (%) | 1 | 1 |
| | | |
| Indicators (n) | 48 | 48 |
| Necessary (%) | 48 | ---- |
| Feasible (%) | ---- | 65 |
| Median 1-3 (n) | 0 | 0 |
| Median 4-6 (n) | 24 | 17 |
| Median 7-9 (n) | 24 | 31 |
| Agreement (%) | 92 | 73 |
| Equivocal (%) | 8 | 27 |
| Disagreement (%) | 0 | 0 |
| | | |
| Indicators (n) | 14 | 14 |
| Necessary (%) | 43 | ---- |
| Feasible (%) | ---- | 29 |
| Median 1-3 (n) | 0 | 0 |
| Median 4-6 (n) | 7 | 7 |
| Median 7-9 (n) | 7 | 7 |
| Agreement (%) | 64 | 29 |
| Equivocal (%) | 21 | 71 |
| Disagreement (%) | 14 | 0 |
*Indicators were divided into three main categories: Structures/Organisational, Clinical Processes, and Outcomes
**One item was not rated by a sufficient number of panellists to obtain a median score
***Five items were not rated by a sufficient number of panellists to obtain a median score